Laser Photonics Corporation reported Q1 2026 financial results, with revenue declining to $0.9 million from $2.3 million year-over-year. Despite lower revenue attributed to the timing of equipment deliveries, the company highlighted significant operational progress, including a major defense contract selection, entry into the medical device market, and a strengthened balance sheet after raising capital.
Key Details
- Financials: Q1 2026 revenue was $0.9 million, resulting in a net loss of $2.9 million. The company ended the quarter with $1.6 million in cash and a combined backlog of approximately $4.2 million.
- Defense Milestone: The company's Laser Shield Anti-Drone System was selected by the U.S. Department of War as a top submission in the "Vulcan" Call for Solutions program, leading to further technical engagement.
- Capital & Balance Sheet: Raised approximately $6.1 million in net proceeds during Q1 and an additional $3.6 million in April 2026. The funds were used to repay all past-due notes payable.
- Commercial & Operational Updates: Secured a $0.25 million order from Johnson & Johnson, marking its entry into medical device manufacturing. Completed manufacturing consolidation, which is expected to generate nearly $1 million in annualized cost savings.